Yose,
In my opinion, I thought the last document needed by the Pink OTC reps was the Attorney's letter that was received on June 15. If this is the case, then the removal of the Caveat should be soon. But that is a big if. Compliance audits can take on a life of their own. I hold shares in another pinkie and their compliance audit for their uplisting has been on going since last November because of supplemental documentation that is requested after each submission. By the way, have you talked to the IR rep, Tyler, lately?
Market Data 
Markets 
AI
